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Abstract
Background: In the absence of definitive diagnosis, healthcare providers are likely to prescribe empirical
antibacterials to those who test negative for malaria. This problem is of critical importance in Southern Asia (SA)
and South-eastern Asia (SEA) where high levels of antimicrobial consumption and high prevalence of antimicrobial
resistance have been reported. To improve management and guide further diagnostic test development, better
understanding is needed of the true causative agents of fever and their geographical variability.
Methods: We conducted a systematic review of published literature (1980–2015) to characterise the spectrum of
pathogens causing non-malarial febrile illness in SA and SEA. We searched six databases in English and French
languages: MEDLINE, EMBASE, Global Health (CABI) database, WHO Global Health Library, PASCAL, and Bulletin de la
Société Française de Parasitologie (BDSP). Selection criteria included reporting on an infection or infections with a
confirmed diagnosis, defined as pathogens detected in or cultured from samples from normally sterile sites, or
serological evidence of current or past infection.
Results: A total of 29,558 records from 19 countries in SA and SEA were screened, of which 2410 (8.1%) met the
selection criteria. Bacterial aetiologies were reported in 1235 (51.2%) articles, viral in 846 (35.1%), parasitic in 132
(5.5%), and fungal in 54 (2.2%), and 143 (6.0%) articles reported more than one pathogen group. In descending
order of frequency, Salmonella Typhi, Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and coagulase
negative Staphylococcus were the commonly reported bacteria, while dengue virus, chikungunya virus, Japanese
encephalitis virus, hepatitis B virus, and hepatitis C virus were common viral pathogens reported. Reports of rarely
reported or emerging pathogens included a case report of Borrelia burgdorferi (Lyme disease) in India in 2010 and
reports of Nipah virus in Singapore and India.
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Conclusions: This review summarises the reported non-malaria pathogens that may cause febrile illness in SA and
SEA. The findings emphasise the need of standardising the reporting of aetiological studies to develop effective,
evidence-based fever management and improved surveillance. Research and development of diagnostic tools
would benefit from up-to-date epidemiological reporting of the regional diversities of non-malaria fever aetiologies.
Trial registration: PROSPERO registration, CRD42016049281
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Background
While a global decline in malaria burden has been re-
ported in the last 15 years, Asia has observed the sharpest
decrease [1, 2]. The most recognised cause of febrile ill-
nesses has gradually shifted from malaria to other infec-
tious diseases in Southern Asia (SA) and South-eastern
Asia (SEA) [3, 4]. In some endemic parts of Asia, as little
as 1% of febrile illnesses among those visiting healthcare
facilities has been attributed to malaria [5, 6]. In these
areas, once malaria is ruled out from the differential diag-
nosis, delineating the cause of febrile illness can be chal-
lenging. Contributing factors include the limited
availability of rapid diagnostic tests (RDTs) for infections
other than malaria and limited microbiology laboratory fa-
cilities for the identification of the microorganisms, many
of which require skilled personnel as well as relatively
complex and expensive equipment and reagents [7]. Im-
proving the diagnosis and management of febrile illnesses
caused by non-malarial pathogens—referred to henceforth
as non-malarial febrile illness (NMFI)—is a regional and
global priority [3, 5, 8, 9]. The World Health Organization
(WHO) has emphasised the need to identify the patho-
gens causing NMFIs for the development of country-
specific algorithms for effective fever management, espe-
cially in primary healthcare facilities [8].
Fever is one of the commonest reasons to seek medical
attention in this region [10]. However, there is a paucity
of information regarding the geography of aetiological
agents of fever for many countries in SA and SEA [4,
11]. With approximately 2.5 billion inhabitants, a third
of the world’s population living in SA and SEA, the scar-
city of information is of upmost importance to guide
public health policies and research and development in-
vestments. This region has seen the emergence, re-
emergence, and spread of several pathogens of serious
threat to global health like dengue, chikungunya, influ-
enza A (H5N1 and H1N1), and different multidrug-
resistant infections among many others [12, 13]. For the
clinician or a health worker in an outpatient clinic in re-
source limited settings, the uncertainty in disease diag-
nosis can prompt indiscriminate use of broad-spectrum
antimicrobials including combinations of antibacterials,
antiparasitics, and antifungals without prior knowledge
of the likely aetiological pathogen or underlying
antimicrobial susceptibility. There are concerns that this
practice promotes antimicrobial resistance (AMR) [14,
15], while rates of antimicrobial consumption are rising
globally [16]. The widespread availability of over-the-
counter antimicrobials, self-medication practices, over-
prescribing, poor information, poor adherence, and the
lack of rapid diagnostics to differentiate infections re-
quiring antimicrobials from those that do not are all po-
tential drivers of AMR in this region [15, 17]. At the
same time, access to life-saving antimicrobials must be
assured for those who need them.
Thus, finding available and pertinent evidence to com-
pensate for the lack of aetiological knowledge of NMFIs
will aid in enhancing surveillance strategies, fever diag-
nostics, and effective fever management and contribute
to antimicrobial stewardship efforts in this densely pop-
ulated region. In line with this, an initial effort was made
in 2012 to map the regional distribution and abundance
of the pathogens in the Mekong sub-region and this pro-
ject expands that work [9].
A major challenge for assimilation of available evi-
dence on NMFI is the dearth of epidemiologically sound,
methodologically rigorous, and standardised evidence.
This precludes us from reliably assessing the distribution
of prevalent fever-causing agents in the SA and SEA re-
gions [11, 18]. In light of this sporadic and non-
standardised reporting of fever research, we conducted
an exhaustive systematic review of all published litera-
ture from 1980 through 2015, including evidence meet-
ing minimal selection criteria to be as inclusive as
possible in studying the reported distribution of the
broad spectrum of pathogens in this region.
Methods
This review was conducted according to the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) statement [19]. The study protocol
is registered with the international prospective register
of systematic reviews (PROSPERO Registration ID:
CRD42016049281).
Literature search strategy
A systematic literature search was carried out in six li-
braries: MEDLINE, EMBASE, WHO Global Health
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Library (SEARO and WPRO files), Global Health
(CABI), Banque de Données Santé Publique (BDSP), and
PASCAL to identify publications from 1980 through
2015. A broad search string was employed which con-
sisted of Medical Subject Headings (MeSH) and free text
terms with no restriction on study design (Supplemental
file 1; section 1.1).
The literature searches for SA and SEA were carried
out separately with different time periods used (Supple-
mental file 1; section 1.1). Restrictions were imposed to
exclude articles published before 1980 and those pub-
lished in languages other than Chinese, English, French,
Portuguese, or Spanish. The corresponding author or
the journal was contacted to provide articles when
necessary.
Study selection and full-text review
The screening was carried out in two stages to identify
the articles fulfilling the inclusion criteria: title and ab-
stract screening (stage I) and then full-text screening
(stage II). Only articles meeting the pre-specified inclu-
sion and exclusion criteria were included. Non-malarial
febrile illness: a systematic review of published
aetiological studies and case reports from Africa, 1980-
2015. Two reviewers assessed the articles for SA (PS)
and SEA (CON) independently—with each article
assessed only once by one of the two reviewers. The
PRISMA flow diagram is presented in Fig. 1, and a sep-
arate flow diagram for SA and SEA reviews is shown in
Supplemental file 1 (Supplemental file 1; section 1.2).
Data extraction
Data from articles deemed eligible for the review were
extracted into a bespoke online data extraction form
built for the purpose of this review. The extracted
variables included the following bibliographic metrics:
study title, names of the first and second author, year
of publication, Uniform Resource Locator (URL), and
the digital object identifier (DOI). Information on the
following study meta-data was extracted: name of the
study site, latitude and longitude of the study site(s),
study start year, study end year, and range of age
groups included. The type of sample, number of indi-
viduals tested, number of cases testing positive for an
organism, and laboratory method/s used were re-
corded for the reported pathogens.
Fig. 1 PRISMA flow diagram, a systematic review of publications from Southern Asia and South-eastern Asia, 1980–2015. *Non-clinical studies =
descriptions of laboratory methods, modelling studies, economic evaluations, opinion pieces, animal model, and studies on medicinal plants. **Other
studies = studies of disease not including laboratory identification of pathogens causing fever (vector transmission, genetic studies, empirical diagnosis)
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Study design
Each of the reports identified in the review was classified
into one of three groups: (i) case report/case series, (ii)
seroprevalence studies, and (iii) fever series. A fever
series was defined as studies where the number of par-
ticipants tested was clearly stated together with the
number of participants testing positive for a given patho-
gen with an accurate diagnostic test for pathogen identi-
fication (culture or molecular methods). Seroprevalence
studies were defined as studies that reported the number
of individuals testing positive for a serological test along
with the total number of tested individuals. The sero-
prevalence studies were further classified into those car-
ried out in symptomatic patients to diagnose acute
infections and the ones carried out in asymptomatic in-
dividuals to measure past exposure or infection.
Categorisation of infections
Infections were categorised as bacterial, fungal, parasitic,
or viral and were sub-categorised using an epidemio-
logical definition based on the predominant mode of
transmission for the pathogens into mutually exclusive
groups as contact (direct, indirect, droplet, or droplet
nuclei transmission), vector-borne, airborne, and food-
and/or water-borne [20].
Study population and geographical classification
Study populations were grouped into four mutually ex-
clusive categories: neonates (aged < 28 days), infants (1
to < 12 months), children (1 to < 13 years), and older in-
dividuals (≥ 13 years). If a study reported any participants
from each age group, then they were grouped as partici-
pants of “all ages”. Countries were classified into sub-
regions (“Southern Asia” and “South-eastern Asia”) ac-
cording to United Nations designation of areas and re-
gions [21].
Statistical analyses and risk of bias assessment
The unit of analysis was a published article for each
pathogen. Articles reporting a given pathogen were
categorised by the UN sub-regions, patient age group
of tested individuals, pathogen class (bacteria, viruses,
fungi, and parasites), and predominant epidemiologic
mode of transmission. The heterogeneity of study de-
sign, pathogens sought, laboratory methods, reporting,
and limitations in data extraction precluded meta-
analysis or estimation of pathogen prevalence. Mul-
tiple articles reporting different pathogens from the
same study were treated as two separate articles. All
analyses were carried out using R software version
3.6.0 (R Foundation for Statistical Computing, Vienna,
Austria), and graphical presentations were done using
ggplot2 library [22].
The currently available tools for assessing the quality
and risk of bias were not applicable to our review design
[23, 24]. We developed criteria specifically for quality as-
sessment of the studies included in this review based on
available information regarding study design and labora-
tory methods used for identification of the pathogens.
We considered case reports and case series at a high risk
of bias as they usually report atypical presentations.
Seroprevalence studies were considered to be at moder-
ate risk of bias as the distinction of acute and past infec-
tions depends on sample timing. For fever series, studies
using culture, polymerase chain reaction (PCR) methods,
or microscopy for detection of parasites were considered
to be at low risk of bias. To assess whether published
data were biased toward urban areas, the distance be-
tween the study location and the nearest major city was
calculated using the coordinates of cities in SA and SEA
available in the “maps” library [25].
Results
The database search identified a total of 29,558 articles,
with 20,442 and 9116 articles for SA and SEA, respect-
ively. Of these, 2410 unique articles were selected for the
final synthesis (Fig. 1). Among these, 1181 (49.0%) were
case series, 585 (24.3%) were seroprevalence studies, 512
(21.2%) were fever series, and 132 (5.5%) articles com-
prised combinations of the aforementioned study types.
Of 711 articles describing seroprevalence studies, 468
were in symptomatic patients, 67 were in asymptomatic
participants, and 174 comprised of both groups (133
were conducted during outbreaks).
Spatial distribution
Data were collected from 2075 unique study sites, 1880
(90.6%) of which were within a radius of 50 km of the
nearest city (Fig. 2). There were 1675 (69.5%) unique ar-
ticles from SA, 732 (30.4%) from SEA, and three (0.1%)
reported from both regions (Fig. 3). In SA, most reports
were from India (n = 1207) followed by Pakistan (n =
194), Nepal (n = 102), Bangladesh (n = 92), and Sri Lanka
(n = 80). Most reports from SEA were from Thailand
(n = 301), followed by Malaysia (n = 154), Singapore (n =
98), Indonesia (n = 58), and Vietnam (n = 52). There
were fewer than 10 reports from each of Afghanistan,
Bhutan, Brunei Darussalam, Maldives, Myanmar, and
Timor-Leste.
Study population
Studies reporting on neonates were found in 176 (7.3%)
articles, infants in 47 (2.0%), children aged 1 to < 13
years in 408 (16.9%), and older children and adults (≥ 13
years) in 764 (31.7%). There were 757 (31.4%) articles
that included participants of all ages, while the age group
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Fig. 2 Location of study sites, systematic review of publications from Southern Asia and South-eastern Asia, 1980–2015. Location of study sites
reported on in this review (in green) augmented with major cities (in red). Data on major cities were obtained from “maps” package in R
software, and for the purpose of this review, only cities with population greater than 100,000 are shown
Fig. 3 Number of publications by country, from Southern Asia and South-eastern Asia, 1980–2015. The total number of studies reported from
each of the country over the review period from 1980 through 2015. Case series included individual case reports or series of patients with the
same condition. Studies were classed as fever series if the total population denominator tested was reported and if an accurate diagnostic test
for pathogen identification (culture or molecular methods) was used. Seroprevalence studies were defined as studies that reported the number
of individuals testing positive using a serological test along with the total number of tested individuals
Shrestha et al. BMC Medicine          (2020) 18:299 Page 5 of 14
studied was not reported in 258 (10.7%) articles (Fig. 4;
upper panel).
Samples collected and diagnostic methods
Blood was the main specimen analysed in 2068 (85.8%)
reports included in this review. Cerebrospinal fluid
(CSF) samples were analysed in 101 (4.2%) articles; both
CSF and blood in 60 (2.5%); bone marrow, joint, lymph,
or liver aspirates in 63 (2.6%); peritoneal, pericardial, or
pleural fluids in 23 (1.0%); spleen samples in 10 (0.4%);
and vitreous humour samples in 10 (0.4%). Multiple
sample sources were analysed in 73 (3.0%) articles, and
the specimen analysed was not specified in two (0.1%)
(Supplemental file 1; section 1.3).
Bacterial infections were detected using culture
methods in 920 (66.8%) articles, serological assays in
340 (24.7%), PCR in 30 (2.2%), and microscopy and
staining in seven (0.5%), and multiple diagnostic
methods were reported in 89 (5.8%) articles. For vi-
ruses, 680 (75.5%) articles reported serological testing,
and 90 (10.0%) PCR methods, 14 (1.6%) culture
methods, and multiple diagnostic methods were re-
ported in 117 (13.0%) articles. Fungal infections were
identified using culture methods in 125 (87.4%) arti-
cles while parasites were detected using microscopy
methods in 70 (51.1%) articles and serological tests in
39 (5.6%) articles. Further details are presented in
Supplemental file 1; section 1.3.
Aetiological findings
Bacterial infections were reported in 1235 (51.2%) arti-
cles, viral infections in 846 (35.1%), parasitic infections
in 132 (5.5%), and fungal infections in 54 (2.2%), and
143 (6.0%) articles reported more than one pathogen
group (Fig. 4; lower panel). The median number of
pathogen species reported in a study was one [range 1–
46, interquartile range 1–2]. Among 2410 articles, 1774
(73.6%) reported one species of microorganisms while 2
to < 5 microorganisms were reported in 319 (13.2%) arti-
cles, between 5 to < 10 in 192 (8.0%) articles, and ≥ 10
microorganisms in 125 (5.2%) articles.
Bacterial infections
Salmonella Typhi (n = 285 articles), Escherichia coli (n =
270), Staphylococcus aureus (n = 255), Klebsiella pneu-
moniae (n = 169), and coagulase negative Staphylococci
(n = 160) were the top five commonly reported bacteria
(Fig. 5). Salmonella Typhi (n = 236) was the most com-
monly reported bacterium in Southern Asia (Fig. 5; left
panel), whereas in South-eastern Asia, Burkholderia
pseudomallei (n = 86) was the most commonly reported
(Fig. 5; right panel).
Vector-borne bacterial infections
Orientia tsutsugamushi was the most commonly re-
ported vector-borne bacterium (n = 151 articles)
followed by Rickettsia typhi (n = 48); Rickettsia, spotted
fever group (n = 37); and Rickettsia spp. (n = 34) (Fig. 5).
Fig. 4 Waffle plots showing the distribution of articles by age categories (top) and pathogen categories (bottom), systematic review of published
aetiological studies and case reports from Southern Asia and South-eastern Asia, 1980–2015
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Orientia tsutsugamushi was reported in 104 (6.2%) arti-
cles from Southern Asia and 47 (6.4%) from South-
eastern Asia. There was a single report of Borrelia burg-
dorferi from India in 2010.
Food- and/or water-borne bacterial infections
Salmonella Typhi (n = 285 articles) was the most com-
mon cause of food- and/or water-borne bacterial infec-
tions, followed by Leptospira spp. (n = 125) and
Burkholderia pseudomallei (n = 108). Among neonates,
Salmonella spp. were reported in seven articles followed
by Burkholderia pseudomallei (n = 6) and Listeria mono-
cytogenes (n = 4); this was similar among children aged 1
to < 13 years. Among adolescent children and adults (≥
13 years), Burkholderia pseudomallei (n = 58), Leptospira
spp. (n = 44), and Salmonella Typhi (n = 37) were the
most common reported pathogens. Burkholderia pseu-
domallei was reported in 86 articles from SEA and 22
from SA. Streptococcus suis was reported in SEA from
Cambodia (n = 1; 2013), Lao PDR (n = 2; 2013–2015),
Vietnam (n = 1; 2008), and Thailand (n = 11; 2003–
2015).
Bacterial infections that spread through contact
Escherichia coli (n = 270 articles), Staphylococcus aureus
(n = 255), and Klebsiella pneumoniae (n = 169) were the
most commonly identified bacteria which spread
through contact. Among neonates, Klebsiella pneumo-
niae was reported in 60 articles, while among children
aged 1 to < 13 years, Streptococcus pneumoniae (n = 54),
Staphylococcus aureus (n = 50), Escherichia coli (n = 45),
Haemophilus influenzae (n = 31), and Pseudomonas aer-
uginosa (n = 27) were the top five commonly reported
bacteria (Fig. 5).
Airborne bacterial infections
Coxiella burnetii was reported in 13 articles and Legion-
ella pneumophila in two articles, and Mycobacterium
chelonae and Legionella spp. were reported in an article
each. Among neonates, Coxiella burnetii (n = 1) was the
only description of airborne bacterial infection, while
there were no reports among older children.
Viral infections
Dengue virus infection was the most commonly reported
viral infection (n = 593) followed by chikungunya virus
(n = 102), Japanese encephalitis virus (n = 71), hepatitis B
virus (n = 35), and hepatitis C virus (n = 33) (Fig. 6).
Among neonates, the distribution of viral infections dif-
fers with 13 articles reporting dengue virus infections
(n = 13), herpes simplex virus (n = 3), chikungunya virus
(n = 2), enterovirus (n = 2), Japanese encephalitis virus
(n = 1), and flavivirus (n = 1). Among infants, dengue
virus (n = 8), rubella virus (n = 2), and an article each re-
ported: chikungunya virus, Coxsackie B virus, hepatitis B
virus, human herpesvirus 6, and B19 virus. Among chil-
dren, dengue virus (n = 118), Japanese encephalitis virus
(n = 28), measles virus (n = 9), hepatitis A virus (n = 7),
and human herpes simplex virus (n = 7) were the top five
commonly reported viruses. Among adults, dengue virus
Fig. 5 Most commonly reported bacterial infections by predominant mode of transmission, Southern and South-eastern Asia, 1980–2015. The
graph presents the top 10 pathogens (based on the number of the published articles) by epidemiological mode of transmission
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(n = 184), chikungunya virus (n = 28), Crimean-Congo
haemorrhagic fever virus (n = 16), hepatitis B virus (n =
15), and Japanese encephalitis virus (n = 12) were the top
five reported viruses. The age-stratified distribution of
the reports on viral infections is presented in Supple-
mental file 1; section 1.3.
Vector-borne viruses
Dengue virus was the most commonly reported arbo-
virus (n = 593) followed by chikungunya virus (n = 102),
Japanese encephalitis virus (n = 71), Crimean-Congo
haemorrhagic fever virus (n = 31), and West Nile virus
(n = 17). Zika virus was reported in an article each from
Indonesia (1981), Pakistan (1983), and the Philippines
(2015).
Food- and/or water-borne viral infections
Hepatitis A virus was reported in 17 articles and hepa-
titis E virus in 16. Human poliovirus was reported in an
article from India (1991), and there was one report de-
scribing Coxsackie B virus from Thailand (1991). There
were no other descriptions of food- and/or water-borne
viral infections.
Airborne viral infections
Hantaan virus (n = 14), measles virus (n = 13), hantavirus
(n = 7), human respiratory syncytial virus (n = 2 articles),
and Sin Nombre virus (n = 1) were the airborne viral in-
fections reported. Hantavirus was reported in an article
each from Cambodia, Indonesia, and Thailand and in
two articles each from India and Singapore.
Viral infections spreading through contact
Hepatitis B virus (n = 35), hepatitis C virus (n = 33), ru-
bella virus (n = 16), and human herpes simplex virus
(n = 12) were the most commonly reported viruses
spreading through contact. Nipah virus was reported
from Malaysia (n = 3, 1999–2002), Singapore (n = 2,
1999–2001), India (n = 1, 2006), and Bangladesh (n = 4,
2006–2012).
Parasitic and fungal infections
Leishmania donovani was the most reported parasite
(n = 50 articles) followed by Leishmania spp. (n = 31),
Wuchereria bancrofti (n = 7), Naegleria fowleri (n = 6),
and Trichinella spp. (n = 6). All of the reported Leish-
mania donovani were from Southern Asia (Fig. 7).
Among fungi, Candida spp. (n = 90) were the most com-
monly reported, with 31 articles describing Candida
albicans, followed by Cryptococcus neoformans (n = 24)
and Candida tropicalis (n = 12) (Fig. 7). The majority of
the reported C. neoformans were in HIV-uninfected
patients.
Spatial and temporal trends in infectious causes of fever
The temporal trend in most commonly reported fever-
causing pathogens over the different time periods is pre-
sented in Tables 1, 2, and 3. In SA, the leading reported
bacterial cause of NMFI was Salmonella Typhi whereas
Fig. 6 Most commonly reported viral infections by predominant mode of transmission, Southern and South-eastern Asia, 1980–2015. The graph
presents the top 10 pathogens (based on the number of the published articles) by epidemiological mode of transmission
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Burkholderia pseudomallei was the most commonly re-
ported cause of NMFI in SEA (Fig. 5). Dengue virus was
the most commonly reported viral cause across different
time periods in both SA and SEA (Fig. 6). Among para-
sites, Leishmania spp. were the most commonly re-
ported parasites in SA, but were not commonly reported
in SEA (Fig. 7). Literature on fungi mostly reported Can-
dida spp. and Cryptococcus spp. (mostly from HIV-
uninfected patients) across the time periods and regions
(Fig. 7).
Pathogens of regional interest or considered as emerging
The distribution of the study sites for some of the
pathogens (Nipah virus, Borrelia burgdorferi, Zika
virus) considered as emerging or of regional interest
is presented in Fig. 8. Streptococcus suis was reported
only in SEA, from Cambodia (n = 1; 2013), Lao PDR
(n = 2; 2013–2015), Vietnam (n = 1; 2008), and
Thailand (n = 11; 2003–2015). Nipah virus was re-
ported from Malaysia (n = 3; 1999–2002), Singapore
(n = 2; 1999–2001), India (n = 1; 2006), and
Bangladesh (n = 4; 2006–2012).
Assessment of risk of bias
Of 2410 included articles, the risk of bias was considered
to be moderate or high in 1181 (49.0%) and low in 1229
(51.0%). Of 2075 studies where it could be ascertained,
1880 (90.6%) were from urban settings or located within
a radius of 50 km of the capital city or another major
city (Supplemental file 2).
Discussion
In order to characterise the aetiological agents of febrile
illnesses in the region, we screened approximately 30,
000 articles and present here the findings from 2410 ar-
ticles published from 1980 through 2015, the largest sys-
tematic review to date on the topic.
The review yielded several findings relevant for the
management of febrile illness. Salmonella Typhi was the
most common cause of bacterial infections in Southern
Asia whereas Burkholderia pseudomallei, the causative
agent of melioidosis, was the most commonly reported
bacterial infection in SEA. The latter was also reported
in 22 articles from India and Bangladesh. A recent mod-
elling study has suggested that melioidosis continues to
be under-diagnosed and under-reported globally [26].
Fig. 7 All reported parasitic and fungal infections by predominant mode of transmission, Southern and South-eastern Asia, 1980–2015. The graph
presents the top 10 pathogens (based on the number of the published articles) by epidemiological mode of transmission
Shrestha et al. BMC Medicine          (2020) 18:299 Page 9 of 14
The high case fatality ratio and the under-diagnosis
of the disease highlight the urgent need for raising
awareness of its presence as a causative pathogen
and improving access to diagnosis in Southern Asia.
Similarly, vector-borne infections such as mite-borne
Orientia tsutsugamushi, the causative pathogen of
scrub typhus, were reported across the region but
with notable geographical gaps with no reports iden-
tified from Myanmar, Pakistan, or Bhutan among
others in the purported “tsutsugamushi triangle”
[27].
Viral aetiologies were reported in 35% of the articles
with the majority reporting dengue, chikungunya, or Jap-
anese encephalitis virus infections. As the most reported
viral infections, it is noteworthy that dengue and chikun-
gunya viruses cause diseases with overlapping symptoms
and hence are prone to misdiagnosis, as co-infections
and co-distribution have been reported in SA and SEA
[28]. Our study identified three reports of Zika virus
(two in the 1980s and one in 2015). Although only spor-
adic cases have been reported from Asia, there is a po-
tential for future outbreaks given the dense growing
population, rapid urbanisation, and presence of the vec-
tor, among other factors [29].
Our review has shown a large heterogeneity in
study site selection, design, conduct, and reporting on
studies of infections that may cause fever. Most of
the studies included in this review were carried out
in major cities or within close distance from major
cities (less than 50 km) or the national capital. The
selection of study sites is often influenced by aca-
demic institutions, logistical considerations, and fund-
ing availability. This limits the generalizability of the
results to the whole country or region and clearly
represents a reporting bias toward urban settings, in
these regions with a predominantly rural population,
as has been reported earlier in a systematic review
aimed at characterising febrile illness in the Greater
Mekong sub-region [9]. Similarly, the age range of
the study population tested was not reported in one
out of every 10 articles, despite this being critical for
interpretation of the epidemiological findings and for
guiding preventive and therapeutic control recom-
mendations. The incidence along with the associated
Table 1 Top five most commonly reported pathogens in Southern Asia, stratified by time period
1980 to ≤ 1990 1991 to ≤ 2000 2001 to ≤ 2010 2011 to ≤ 2015
Bacteria Salmonella Typhi (n = 12) Salmonella Typhi (n = 51) Salmonella Typhi (n = 96) Escherichia coli (n = 111)
Salmonella Paratyphi A (n = 5) Staphylococcus aureus (n = 16) Escherichia coli (n = 63) Staphylococcus aureus (n = 98)
Salmonella spp. (n = 2) Coagulase negative
Staphylococcus (n = 14)
Staphylococcus aureus (n = 61) Salmonella Typhi (n = 77)
Pseudomonas aeruginosa (n = 2) Escherichia coli (n = 14) Leptospira spp. (n = 46) Orientia tsutsugamushi (n = 74)
Klebsiella spp. (n = 2) Klebsiella pneumoniae (n = 13) Streptococcus pneumoniae (n = 38) Acinetobacter spp. (n = 72)
Viruses Japanese encephalitis virus (n = 5) Dengue virus (n = 41) Dengue virus (n = 166) Dengue virus (n = 210)
Dengue virus (n = 4) Japanese encephalitis
virus (n = 5)
Chikungunya virus (n = 36) Chikungunya virus (n = 38)
West Nile virus (n = 3) Hepatitis B virus (n = 4) Japanese encephalitis
virus (n = 16)
Japanese encephalitis
virus (n = 23)
CCHF virus (n = 3) West Nile virus (n = 3) CCHF virus (n = 11) CCHF virus (n = 13)
Sandfly fever Sicilian
virus (n = 2)
Hepatitis C virus (n = 3) Hepatitis C virus (n = 8) West Nile virus (n = 8)
Parasites Leishmania donovani (n = 3) Leishmania spp. (n = 12) Leishmania donovani (n = 25) Leishmania spp. (n = 13)
Toxoplasma spp. (n = 1) Leishmania donovani (n = 10) Leishmania spp. (n = 6) Leishmania donovani (n = 12)
Toxocara canis (n = 1) Wuchereria bancrofti (n = 3) Naegleria fowleri (n = 4) Trypanosoma lewisi (n = 2)
Acanthamoeba culbertsoni (n = 1) Naegleria spp. (n = 1) Wuchereria bancrofti (n = 3) Wuchereria bancrofti (n = 1)
– Brugia malayi (n = 1) Trypanosoma evansi (n = 3) Trypanosoma evansi (n = 1)
Fungi Candida spp. (n = 1) Candida albicans (n = 5) Candida spp. (n = 10) Candida spp. (n = 29)
– Candida spp. (n = 2) Cryptococcus neoformans (n = 7) Candida albicans (n = 11)
– Cryptococcus spp. (n = 1) Candida albicans (n = 6) Candida tropicalis (n = 4)
– Cryptococcus neoformans (n = 1) Yeast (n = 3) Candida glabrata (n = 4)
– Candida tropicalis (n = 1) Cryptococcus spp. (n = 3) Cryptococcus neoformans (n = 3)
CCHF Crimean-Congo haemorrhagic fever virus. The number in parentheses indicates the number of publications reporting the given microorganism
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morbidity and mortality of different aetiologies varies
between different age groups. Furthermore, absence
of data on age limits the usefulness of these datasets
for further inclusion in meta-analyses. Similarly,
reporting of laboratory methods was variable. The re-
cently published Microbiology Investigation Criteria
for Reporting Objectively (MICRO) guideline which
aims to standardise reporting of such studies might
be a useful resource to consider for reporting and
reviewing aetiological studies [30].
Our review shares many of the limitations discussed in
the preceding articles in this series [31]. As in the NMFI
Africa review, restricting the inclusion criteria to studies
investigating blood and other sterile fluids meant that sev-
eral important causes of NMFI were excluded. Two exam-
ples of this in SA and SEA are enterovirus and influenza
infections. A very low number of articles describing these
were identified, despite the known high burden of hand,
foot, and mouth disease and viral respiratory illnesses in
the region [32]. These viruses are usually diagnosed by
PCR analysis of the nasopharyngeal or throat swabs, or
faecal samples, and hence, the stringent criteria of includ-
ing only those articles that analysed sterile sample sources
explain this discrepancy. Of note, the absence of reports
on a specific pathogen from a country cannot be taken as
definitive evidence of its absence. Our review found very
few reports of a pathogen being tested for and found to be
negative. Some of the reasons behind this could be publi-
cation bias through publication of reports with only posi-
tive findings, the diagnostic testing being driven by the
interest of the researchers, or the availability/or lack of the
relevant diagnostic resources.
There were some additional limitations specific to this
review. We inadvertently failed to include studies from
Iran, formally recognised as a part of Southern Asia by the
UN. We also searched for articles only in a limited num-
ber of languages and did not search for publications in
local languages. The articles were assessed by one
Table 2 Top five most commonly reported pathogens in South-eastern Asia, stratified by time period
1980 to ≤ 1990 1991 to ≤ 2000 2001 to ≤ 2010 2011 to ≤ 2015
Bacteria Burkholderia pseudomallei
(n = 11)
Burkholderia pseudomallei
(n = 16)
Burkholderia pseudomallei
(n = 34)
Staphylococcus aureus
(n = 26)
Staphylococcus aureus
(n = 9)
Staphylococcus aureus
(n = 15)
Escherichia coli (n = 32) Escherichia coli (n = 26)
Escherichia coli (n = 8) Escherichia coli (n = 14) Staphylococcus aureus
(n = 29)
Burkholderia pseudomallei
(n = 25)
Coagulase negative
Staphylococcus (n = 7)
Klebsiella pneumoniae
(n = 13)
Salmonella Typhi
(n = 25)
Klebsiella pneumoniae
(n = 18)
Orientia tsutsugamushi
(n = 7)
Streptococcus pneumoniae
(n = 10)
Pseudomonas aeruginosa
(n = 23)
Streptococcus pneumoniae
(n = 16)
Viruses Dengue virus (n = 13) Dengue virus (n = 31) Dengue virus (n = 86) Dengue virus (n = 42)
Japanese encephalitis virus
(n = 3)
Japanese encephalitis virus
(n = 5)
Chikungunya virus
(n = 14)
Chikungunya virus
(n = 13)
Human cytomegalovirus
(n = 2)
Nipah virus (n = 3) Japanese encephalitis
virus (n = 10)
Hepatitis B virus (n = 5)
Hantavirus (n = 2) Human herpesvirus 6 (n = 3) Hepatitis C virus (n = 10) Japanese encephalitis
virus (n = 4)
Hantaan virus (n = 2) Hepatitis C virus (n = 2) Hepatitis B virus (n = 8) Human herpes simplex
virus (n = 4)
Parasites Naegleria fowleri (n = 1) Trichinella spp. (n = 2) Trichinella spiralis (n = 2) Trichinella spp. (n = 3)
– Toxoplasma gondii (n = 1) Angiostrongylus cantonensis
(n = 2)
Toxoplasma gondii
(n = 1)
– Toxocara canis (n = 1) Trypanosoma spp. (n = 1) Leishmania siamensis (n = 1)
– Cysticercus spp. (n = 1) Trypanosoma lewisi (n = 1) Leishmania martiniquensis (n = 1)
– – Toxoplasma spp. (n = 1) Gnathostoma spp. (n = 1)
Fungi Cryptococcus neoformans (n = 2) Cryptococcus neoformans (n = 3) Cryptococcus neoformans (n = 6) Candida spp. (n = 10)
Penicillium marneffei (n = 1) Prototheca wickerhamii (n = 1) Candida spp. (n = 4) Candida albicans (n = 6)
Cryptococcus laurentii (n = 1) Histoplasma capsulatum (n = 1) Candida tropicalis (n = 2) Cryptococcus spp. (n = 4)
Cryptococcus albidus (n = 1) Hansenula anomala (n = 1) Candida albicans (n = 2) Penicillium spp. (n = 2)
Candida spp. (n = 1) Geotrichum candidum (n = 1) Scopulariopsis brevicaulis (n = 1) Cryptococcus neoformans (n = 2)
The number in parentheses indicates the number of publications reporting the given microorganism
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independent reviewer owing to the broad scale of this re-
view. Finally, a large proportion of the studies included in
this review were considered to be at high risk of bias and
the results of this systematic review should be interpreted
taking this into consideration (Supplemental file 2).
Despite the limitations, our review provides several note-
worthy observations that warrant additional awareness
among researchers and clinicians in the region. Lyme dis-
ease, a tick-borne disease usually reported in Europe and
North America [33], has seldom been reported in SA with
only a few case reports found in the literature recently [34–
36]. Praharaj et al. reported a prevalence of 13% (65/500) of
anti-Borrelia burgdorferi antibodies in a seroprevalence
study conducted in 2008 in North-Eastern states of India
bordering with China [37]. Moreover, the report of Lyme
disease from southern India (Karnataka state) in 2010 [38]
along with other recent publications suggests that the dis-
ease might potentially pose an emerging threat in the In-
dian sub-continent and should be considered in the
differential diagnosis of NMFIs. Nipah virus, a highly patho-
genic paramyxovirus, now listed as a priority pathogen by
the WHO, was reported in 10 articles from Malaysia,
Singapore, India, and Bangladesh. Similarly, Streptococcus
suis was reported in 15 articles from 2003 through 2015, all
of which were in SEA countries. The high density of pig
farming in the region and the relation to dietary preferences
are thought to contribute to the transmission of this bacter-
ium which is an important cause of meningitis in the region
Table 3 Commonly reported bacterial pathogens among neonates, stratified by sub-regions and time period
1980 to ≤ 1990 1991 to ≤ 2000 2001 to ≤ 2010 2011 to ≤ 2015
SA Citrobacter spp. (n = 2) Coagulase negative
Staphylococcus (n = 6)
Escherichia coli (n = 26) Escherichia coli (n = 44)
Streptococcus spp. (n = 1) Staphylococcus aureus (n = 6) Staphylococcus aureus (n = 24) Staphylococcus aureus (n = 39)
Coagulase negative
Staphylococcus (n = 1)
Klebsiella pneumoniae (n = 4) Klebsiella pneumoniae (n = 19) Coagulase negative
Staphylococcus (n = 37)
Staphylococcus aureus (n = 1) Escherichia coli (n = 4) Acinetobacter spp. (n = 15) Klebsiella pneumoniae (n = 31)
Salmonella spp. (n = 1) Acinetobacter spp. (n = 4) Coagulase negative
Staphylococcus (n = 13)
Acinetobacter spp. (n = 28)
SEA Staphylococcus aureus (n = 4) Streptococcus agalactiae (n = 2) Klebsiella spp. (n = 3) Escherichia coli (n = 7)
Coagulase negative
Staphylococcus (n = 3)
Streptococcus, viridans
group (n = 1)
Streptococcus agalactiae (n = 2) Staphylococcus aureus (n = 6)
Escherichia coli (n = 3) Coagulase negative
Staphylococcus (n = 1)
Stenotrophomonas spp. (n = 2) Streptococcus agalactiae (n = 5)
Streptococcus spp. (n = 2) Staphylococcus aureus (n = 1) Coagulase negative
Staphylococcus (n = 2)
Acinetobacter baumannii (n = 5)
Streptococcus pyogenes (n = 2) Pseudomonas spp. (n = 1) Pseudomonas spp. (n = 2) Coagulase negative
Staphylococcus (n = 4)
SA Southern Asia, SEA South-eastern Asia. The number in parentheses indicates the number of publications reporting the given microorganism
Fig. 8 Pathogens of regional interest or emerging pathogens, publications from Southern Asia and South-eastern Asia, 1980–2015. The map
shows the location of study sites reporting each pathogen
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[39]. In regions with a high density of pig farming, this
should be considered as a potential cause of febrile
illnesses.
Some of these infections can be relatively benign and
self-limiting (e.g. some viral infections) while others (e.g.
Burkholderia pseudomallei, Nipah virus) without omit-
ting malaria are life threatening. Southern Asia and
South-eastern Asia are major hotspots for infectious dis-
eases with almost a third of humanity being at risk [12].
A non-localised febrile illness is a common feature of
these infectious diseases at presentation. Accurate and
prompt diagnosis can be difficult in the absence of reli-
able point-of-care diagnostics, resulting in misdiagnosis
and inappropriate prescription of broad-spectrum anti-
microbials [40–42]. This highlights an urgent need for
development of epidemiologically targeted diagnostic
tools for detecting the causes of febrile illness.
Conclusions
The map of pathogen distributions presented in this re-
view provides regional data that can form a basis for tar-
geted development of diagnostic tools and fever case
management strategies in SA and SAE.
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